A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells

被引:115
作者
Roitbak, T
Ward, CJ
Harris, PC
Bacallao, R
Ness, SA
Wandinger-Ness, A [1 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[3] Indiana Univ, Med Ctr, Dept Med, Indianapolis, IN 46202 USA
[4] Mayo Clin, Div Nephrol, Rochester, MN 55905 USA
关键词
D O I
10.1091/mbc.E03-05-0296
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is typified by the accumulation of fluid-filled cysts and abnormalities in renal epithelial cell function. The disease is principally caused by mutations in the gene encoding polycystin-1, a large basolateral plasma membrane protein expressed in kidney epithelial cells. Our studies reveal that, in normal kidney cells, polycystin-1 forms a complex with the adherens junction protein E-cadherin and its associated catenins, suggesting a role in cell adhesion or polarity. In primary cells from ADPKD patients, the polycystin-1/polycystin-2/E-cadherin/beta-catenin complex was disrupted and both polycystin-1 and E-cadherin were depleted from the plasma membrane as a result of the increased phosphorylation of polycystin-1. The loss of E-cadherin was compensated by the transcriptional upregulation of the normally mesenchymal N-cadherin. Increased cell surface N-cadherin in the disease cells in turn stabilized the continued plasma membrane localization of beta-catenin in the absence of E-cadherin. The results suggest that enhanced phosphorylation of polycystin-1 in ADPKD cells precipitates changes in its localization and its ability to form protein complexes that are critical for the stabilization of adherens junctions and the maintenance of a fully differentiated polarized renal epithelium.
引用
收藏
页码:1334 / 1346
页数:13
相关论文
共 61 条
[1]  
Angst BD, 2001, J CELL SCI, V114, P629
[2]   Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease [J].
Arnaout, MA .
ANNUAL REVIEW OF MEDICINE, 2001, 52 :93-123
[3]   The polycystic kidney disease 1 gene product mediates protein kinase C α-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1 [J].
Arnould, T ;
Kim, E ;
Tsiokas, L ;
Jochimsen, F ;
Grüning, W ;
Chang, JD ;
Walz, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6013-6018
[4]  
BALSAMO J, 1990, J BIOL CHEM, V265, P2923
[5]   Protein kinase C inhibits the transplasma membrane influx of Ca2+ triggered by 4-aminopyridine in Jurkat T lymphocytes [J].
Barbar, E ;
Rola-Pleszczynski, M ;
Payet, MD ;
Dupuis, G .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1622 (02) :89-98
[6]   PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2 [J].
Bhunia, AK ;
Piontek, K ;
Boletta, A ;
Liu, LJ ;
Qian, F ;
Xu, PN ;
Germino, FJ ;
Germino, GG .
CELL, 2002, 109 (02) :157-168
[7]   Functional polycystin-1 expression is developmentally regulated during epithelial morphogenesis in vitro:: downregulation and loss of membrane localization during cystogenesis [J].
Bukanov, NO ;
Husson, H ;
Dackowski, WR ;
Lawrence, BD ;
Clow, PA ;
Roberts, BL ;
Klinger, KW ;
Ibraghimov-Beskrovnaya, O .
HUMAN MOLECULAR GENETICS, 2002, 11 (08) :923-936
[8]  
Calvet JP, 1998, J NEPHROL, V11, P24
[9]   CYST-DERIVED CELLS DO NOT EXHIBIT ACCELERATED-GROWTH OR FEATURES OF TRANSFORMED-CELLS INVITRO [J].
CARONE, FA ;
NAKAMURA, S ;
SCHUMACHER, BS ;
PUNYARIT, P ;
BAUER, KD .
KIDNEY INTERNATIONAL, 1989, 35 (06) :1351-1357
[10]   Cadherins and the tumour progression: is it all in a switch? [J].
Cavallaro, U ;
Schaffhauser, B ;
Christofori, G .
CANCER LETTERS, 2002, 176 (02) :123-128